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We cloned the gene specified by African monkey kidney cells (Vero) that codes for the homolog of the herpes virus entry
mediator (HveA) specified by HeLa cells. The primary sequence of the monkey HveA (HveAs) differed significantly from
HveA. Single amino acid differences were distributed throughout the amino and carboxyl terminal portions of the HveAs in
comparison with the HveA, whereas certain regions were highly conserved. The predicted membrane spanning domains of
the two receptors differed substantially due to insertions and deletions of short amino acid sequences. The ability of HveAs
to mediate HSV virus entry was tested in a series of experiments using the recombinant virus KOS/EGFP, which constitutively
expressed the enhanced green fluorescence protein (EGFP) and Chinese hamster ovary cells (CHO) transformed with the
HveAs gene. The KOS/EGFP virus was constructed by inserting an EGFP gene cassette within the intergenic region between
the UL53 (gK) and UL54 (ICP27) genes. The KOS/EGFP virus formed viral plaques and replicated as well as the wild-type KOS
virus. HveAs-transformed CHO cells constitutively expressing HveAs mediated herpesvirus entry efficiently, whereas cells
transformed with the HveAs gene in the noncoding orientation did not mediate virus entry. A genetically engineered protein
composed of the amino-terminal portion of the HveAs protein fused to the heavy chain of mouse IgG immunoglobulin as well
as mouse antibodies raised against HveAs blocked virus entry into HveAs-transformed CHO cells. Thus, HveAs is the
functional homolog of HveA. © 1999 Academic Press
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(INTRODUCTION
Early steps during productive infection of eukaryotic
ells by herpes simplex virus include initial binding of
irions to cell surfaces mediated by binding of viral
lycoproteins gB and gC onto glycosaminoglycan chains
hat are ubiquitous on most cell surfaces (Spear, 1993).
irion penetration into cells occurs via the pH-indepen-
ent fusion of the viral envelope with the cell membrane
r an early endosome (Wittels and Spear, 1991) and is
ediated by at least viral glycoproteins gB, gD, and
H-gL hetero-oligomers (Sarmiento et al., 1979; Cai et al.,
988; Ligas and Johnson, 1988; Forrester et al., 1992;
oop et al., 1993).
A gD receptor for virus entry, HveA, is an additional
ember of the tumor necrosis factor receptor family
Montgomery et al., 1996; Whitbeck et al., 1997; Geraghty
t al., 1998). HveA is expressed in various tissues, in-
luding liver, lung, kidney, spleen, and peripheral leuco-
ytes, and it is the principal receptor for entry into human
ymphoid cells but not into other cell types (Montgomery
t al., 1996). The cytoplasmic region of HveA binds to
everal members of the tumor necrosis factor-associ-
ted factor (TRAF) family, such as TRAF1, TRAF2, TRAF3,
nd TRAF5 but not to TRAF6. Transient transfection of
VEM (HveA) into human 293 cells causes activation ofm1 To whom reprint requests should be addressed.
365uclear factor-kB (NF-kB), a transcriptional regulator of
ultiple immunomodulatory and inflammatory genes as
ell as activation of the Jun-containing transcription fac-
or AP-1, a regulator of cellular stress-response genes.
hese results suggest that HveA is associated with sig-
al transduction pathways that activate the immune re-
ponse (Marsters et al., 1997).
A second receptor for virus entry, HveB, is the polio-
irus receptor-related protein 2 (Prr2). HveB mediates
SV-2 but not wild-type HSV-1 viral entry (Eberle et al.,
995). Apparently certain mutants of HSV-1 use HveB for
iral entry, and HveB but not HveA mediates pseudora-
ies virus entry. A third receptor, HveC, is the poliovirus
eceptor-related protein 1 (Prr1), which is a human mem-
er of the immunoglobulin superfamily (Lopez et al.,
995). HveC mediates entry of several alphaherpesvi-
uses, including HSV-1 and -2, pseudorabies virus (PRV),
nd bovine herpesvirus-1 (BHV-1). HveC is expressed in
uman cells of epithelial and neuronal origin and is the
rimary candidate for the coreceptor that mediates
SV-1 and -2 viral entry into epithelial cells on mucosa
urfaces and virus spread to cells of the nervous system
Geraghty et al., 1998). A fourth receptor, HveD, is the
oliovirus receptor Pvr (Mendelsohn et al., 1989). HveD
ediates the entry of PRV and BHV-1 but not of HSV-1
Geraghty et al., 1998).
African green monkey kidney (Vero) cells are com-only used for the propagation of HSV-1 in many her-
0042-6822/99 $30.00
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366 FOSTER, CHOULJENKO, AND KOUSOULASesvirus laboratories as well as for the determination of
SV-1 virus entry and egress. Therefore we cloned, se-
uenced, and characterized the Vero HveA homolog,
esignated here as HveAs. Functional characterization
f HveAs for HSV-1 virus entry was accomplished
hrough the construction and use of a recombinant virus
onstitutively expressing the enhanced green fluores-
ence protein (EGFP) while retaining wild-type KOS-like
haracteristics. Our results indicate that HveAs is the
unctional homolog of HveA.
RESULTS
onstruction and genetic characterization of the
ecombinant virus HSV-1 (KOS)/EGFP
Recently, we constructed the recombinant virus DgK/
GFP expressing an engineered enhanced green fluo-
escent protein (EGFP) from a gene cassette inserted in
lace of the glycoprotein K (gK) gene (Foster et al., 1999).
o facilitate our studies on HSV-1 entry, we engineered
he virus KOS/EGFP constitutively expressing EGFP by
nserting the HCMV-EGFP gene cassette into the inter-
enic region between the UL53 (gK) and the UL54
ICP27) genes. First, plasmid pTF9202 was constructed
o contain the HCMV-EGFP cassette in the intergenic
egion between the UL53 and UL54 genes. Next, the
eleted ICP27-UL54 region of the d27–1 viral genome
as rescued by plasmid pTF9202, while simultaneously
ransferring the CMV-EGFP gene cassette into the viral
enome (Fig. 1). Similar methodologies were used to
onstruct the DgK virus (Jayachandra et al., 1997) and the
gK/EGFP virus (Foster et al., 1999). Virus stocks from
arker-rescue experiments were collected, individual
irus plaques were plaque purified five times, and virus
solates were tested by diagnostic PCR. Primer gKTr2 is
ocated within the deleted portion of the UL54 gene (Fig.
c). Amplification with this primer is possible only if the
L54 gene has been rescued by the pTF9202 plasmid.
omplementary DNA sequences to primer gKTr2 are
resent in plasmid pTF9202 immediately upstream and
ownstream of the CMV/EGFP gene cassette. (Figs. 1c
nd 1d). Therefore amplification with primer pair
L52KpnI2/gKTr2 generated two DNA fragments of 1569
nd 3261 bp against KOS/EGFP viral DNA (Fig. 1e, lane
), while only the 1569-bp DNA fragment was generated
gainst KOS viral DNA (Fig. 1e, lane 2). Primer pair
L52KpnI2/CMVBamHI detected the presence of the
GFP gene cassette within the KOS/EGFP viral genome
s evidenced by the PCR-amplified DNA fragment of
401 bp (Fig. 1e, lane 5), whereas it did not produce a
CR product against the KOS viral genome (Fig. 1e, lane
). Additional PCR testing was performed to ensure that
he KOS/EGFP virus was not contaminated with the
27–1 virus using primer pair UL52KpnI2/d27–1a (Fig.
b). This primer pair produced the predicted size DNAragments of 3241 and 1613 bp against KOS and d27–1 ciruses (Fig. 1e, lanes 6, and 8, respectively), and the
redicted DNA fragment of 4889 bp against the KOS/
GFP virus (Fig. 1e, lane 7). A second DNA fragment of
50 bp was of nonspecific origin.
laque phenotype, EGFP expression, and growth
haracteristics of the KOS/EGFP virus
The KOS/EGFP virus produced viral plaques similar in
ppearance to those produced by the wild-type virus
OS (Figs. 2a and 2c). Bright green fluorescence was
etected in all infected cells when viral plaques were
xamined under the fluorescent microscope (Fig. 2b).
luorescence from Vero cells infected with either KOS or
OS/EGFP viruses at an m.o.i. of 5 was detected using
ACS at 24 h p.i. Nearly, all KOS/EGFP-infected cells
mitted bright fluorescence, whereas KOS-infected cells
id not emit any fluorescence (Fig. 2d).
To determine the replication characteristics of the
OS/EGFP virus, Vero cell monolayers were infected in
riplicates with either KOS or KOS/EGFP virus at a m.o.i.
f 10, and virus stocks were prepared at 12, 24, 36, and
8 h p.i. The KOS/EGFP virus replicated to high titers
pproaching those of the KOS parental virus (Table 1).
solation of the gene coding for the Vero HveA
omolog (HveAs) and comparison of the HveA
nd HveAs predicted amino acid sequences
Primers specific for the HveA gene were used to
solate and clone the HveAs cDNA specified by Vero
ells. Translation of the largest open reading frame of the
veAs cDNA sequence produced a putative protein of
83 amino acids sharing a high degree of homology with
he previously described HveA receptor gene (Montgom-
ry et al., 1996). On the basis of the homology to HveA,
his protein was designated the HveA simian homolog
HveAs). A comparison of the predicted amino acid se-
uences of HveA and HveAs is shown in Fig. 3. The two
roteins were of equal length (283 amino acids) but
ontained a number of amino acid differences including
i) 41 amino acid substitutions of which 24 were to similar
mino acids and 17 were to dissimilar amino acids. And
ii) amino acid deletions and insertions principally lo-
ated within the intramembrane sequences. Specifically,
veAs contained a single amino acid insertion (aa 187 of
veAs) and a single amino acid deletion (aa 212 of HveA)
nd a segment of deleted amino acids (aa 216–218 of
veA) and inserted amino acids (aa 216 and aa 222–226
f HveAs). Characteristically, the carboxyl terminus of
veA contained three extra amino acids (P-N-H) in com-
arison with HveAs.
unctional characterization of the HveAs receptor
The ability of HveAs to mediate HSV-1 virus entry was
ssessed through the use of HveAs-transformed CHO
ells, anti-HveAs antibody, and soluble HveA protein.
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367SIMIAN HveA-MEDIATED ENTRY OF HERPES SIMPLEX VIRUS 1nti-HveAs serum was produced by genetic immuniza-
ion using plasmid pCMV/HveAs, and it was tested for its
bility to react with HveAs expressed in Escherichia coli
s a fusion protein with the maltose-binding protein
MBP). Anti-HveAs serum reacted with a protein species
igrating with an apparent molecular mass of 70 kDa in
FIG. 1. Construction of recombinant KOS and DgK viruses constitu
rrangement of the HSV-1 genome indicating approximate map units. (
L53, and the partially deleted UL54 genes with relevant restriction end
assette in place of the gK gene (Foster et al., 1999). (d) Plasmid pTF92
f plasmid pTF9201. The approximate location of PCR primers, UL52K
urified KOS/EGFP recombinant virus. DNA PCR products with the UL52
air (lanes 4 and 5) used to detect the EGFP gene. Lanes 6–8: PCR di
iral stocks. Lanes 2, 4, and 6: KOS viral DNA. Lanes 3, 5, and 7: KOS/EG
ith HindIII (marker). Lane 9: 1-kb molecular weight ladder.greement with the expected apparent molecular mass if electrophoretically separated MBP/HveAs fusion pro-
ein (Fig. 4a, lane 2 of immune samples). Anti-HveAs
erum did not react against MBP expressed in E. coli
Fig. 4a, lane 1 of immune samples). Similarly, pre-im-
une sera did not react with either MBP or MBP/HveAs
roteins (Fig. 4a, lanes 1 and 2, respectively, of pre-
xpressing the EGFP gene. (a) The top line represents the prototypic
region of the mutant virus HSV-1 d27–1 genome containing the UL52,
ase sites. (c) Plasmid pTF9201, which contains the CMV-IE-EGFP gene
produced by inserting the gK gene within the unique KpnI/SpeI sites
KTr2, and CMVBamHI are shown (b–d). (e) Diagnostic PCR of plaque
gKTr2 primer pair (lanes 2 and 3) or the UL52KpnI2/CMVBamHI primer
ic with primer pair UL52KpnI2/d27–1a used to determine the purity of
al DNA. Lane 8: d27–1 viral DNA. Lane 1: lambda phage DNA digestedtively e
b) The
onucle
02 was
pnI2, g
KpnI2/
agnost
FP virmmune samples).
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368 FOSTER, CHOULJENKO, AND KOUSOULASNext, CHO cells were transformed with either pCMV/
veAs or pCMV/sAevH. Plasmid pCMV/sAevH contains
he HveAs gene in the opposite (noncoding) orientation.
veAs expression by CHO/HveAs and Vero cells was
ssessed using anti-HveAs serum and FACS analysis.
FIG. 2. Morphology and fluorescence detection of KOS/EGFP viral pl
) at an m.o.i. of 0.001 in 24-well plastic tissue culture plates. Individua
) and epi-fluorescence (b) microscope under live conditions at 48 h
erformed at 48 h p.i. (d) as described previously (Foster et al., 1999).
TABLE 1
Viral yields of KOS and KOS/EGFP viruses
Virus
Titer (PFU/ml)
12 h p.i. 24 h p.i. 36 h p.i. 48 h p.i.
OS 5.0 3 107 1.5 3 108 2.0 3 108 2.0 3 108
OS-EGFP 3.0 3 107 1.0 3 108 1.4 3 108 1.5 3 108
Note. Subconfluent Vero cell monolayers (approximately 8 3 105
ells) were infected with each virus at an MOI of 5, and at 12, 24, 36,
nd 48 h.p.i. the total number of infectious virions was determined. Viral
ields represent one of three experiments in which individual numbersaaried by less than 2-fold.nti-HveAs serum reacted strongly with paraformalde-
yde-fixed Vero cells and CHO/HveAs cells (Figs. 4b and
c, respectively, solid histograms). No background fluo-
escence was observed in control experiments in which
ero cells were incubated with pre-immune sera prior to
ncubation with goat-anti-mouse FITC-conjugate (Fig. 4b,
nfilled histogram). Anti-HveAs antibody did not react
ith CHO/sAevH cells (Fig. 4c, unfilled histogram).
To facilitate virus entry blocking experiments, soluble
veAs protein was produced by first, constructing a
ene cassette coding for the extracellular portion of
veAs fused to the Fc portion of mouse IgG. Next CHO
ells were transformed with plasmid pCR/HveAs:Fc ca-
able of constitutively expressing HveAs:Fc protein, and
veAs:Fc protein was purified from supernatant fluids of
hese cells using protein A sepharose beads (see Ma-
erials and Methods). The authenticity of HveAs:Fc pro-
ein was tested in immunoblots using anti-mouse-IgG
Vero cells were infected with either KOS (c) or KOS/EGFP virus (a and
laques were photographed through the use of phase-contrast (a and
CS analysis of KOS- and KOS/EGFP-infected cells (m.o.i. of 5) wasaques.
l viral p
p.i. FAntibody. A protein species with an apparent molecular
m
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369SIMIAN HveA-MEDIATED ENTRY OF HERPES SIMPLEX VIRUS 1ass of ;60 kDa was detected in immunoblots of elec-
rophoretically separated HveAs:Fc protein (Fig. 5, lane
FIG. 3. Comparison of the amino acid sequences of the HveAs and H
ere aligned through the use of computer-assisted algorithms and vi
eatures of both proteins are marked as indicated.), whereas anti-mouse IgG antibody did not react with tupernatants from CHO/sAevH control cells (Fig. 5, lane
). The HveAs:Fc-purified protein was sensitive to diges-
The HveAs (top lines) and HveA (bottom lines) amino acid sequences
pection. Both proteins are 283 amino acids long. Relevant structuralveAh.ion by PNGase F, indicating that it contained N-glycosy-
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370 FOSTER, CHOULJENKO, AND KOUSOULASated carbohydrates (not shown). A glycosylated protein
ith similar apparent mass was produced by a HveA:Fc
usion protein (Montgomery et al., 1996)
Virus-entry experiments were performed by monitoring
GFP expression specified by KOS/EGFP virus. KOS/
FIG. 4. Detection of HveAs expression in E. coli, Vero, and HveAs-
horetically separated HveAs/MBP fusion protein after expression in E.
nd immune sera were tested as shown. Lanes labeled 1: MBP contro
y FACS after reaction with either anti-HveAs antibody followed by rea
re-immune sera as primary antibody (unfilled histogram). (c) CHO/HveA
ere analyzed by FACS to detect HveAs using anti-HveAs antibody.
FIG. 5. Immunoblot detection of HveA:Fc expression from CHO/
veAs:Fc-transformed cells. Supernatants from either HveAs:Fc trans-
ormed CHO cells or naive CHO/sAevH control cells were subjected to
rotein A sepharose purification and prepared for immunoblot analysis.
mmunoblots were reacted with goat-anti-mouse HRP reagent. Lane 1:
eaction with supernatant concentrate from CHO cells. Lane 2: reactiontith supernatant concentrate from HveAs:Fc-transformed CHO cells.GFP infection (m.o.i. of 5) of CHO/HveAs cells resulted
n most cells emitting green fluorescence at 24 h p.i.,
ndicating successful viral entry (Fig. 6A). In contrast,
ractically none of the KOS/EGFP-infected CHO/sAevH
ontrol cells emitted fluorescence (Fig. 6B). Next exper-
ments were performed using the soluble HveAs:Fc pro-
ein. Pre-incubation of KOS/EGFP virions with superna-
ant fluids from CHO/sAevH control cells did not reduce
he number of fluorescent cells, whereas pre-incubation
ith purified HveAs:Fc protein reduced the number of
luorescent cells substantially (Figs. 6C and 6D, respec-
ively). Similarly, treatment of the CHO/HveAs cells with
re-immune control serum prior to infection with KOS/
GFP virus did not reduce the number of fluorescent
ells, whereas treatment with anti-HveAs antibody serum
aused a substantial decrease in the number of fluores-
ent cells (Figs. 6E and 6F, respectively).
DISCUSSION
We report here the functional characterization of the
erpes simplex HveA receptor homolog specified by
frican green monkey kidney cells, designated here as
veAs. These studies were undertaken because Vero
ells constitute our primary cells in which virus entry and
gress are studied. Investigation of the ability of HveAs
rmed CHO cells using anti-HveAs serum. (a) Immunoblot of electro-
ing anti-HveAs serum produced by genetic immunization. Pre-immune
s labeled 2: MBP/HveAs fusion protein. (b) Vero cells were analyzed
ith anti-mouse-IgG labeled with fluorescein (filled histogram) or with
d histograms)- and CHO/sAevH (unfilled histograms)-transformed cellstransfo
coli us
l. Lane
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371SIMIAN HveA-MEDIATED ENTRY OF HERPES SIMPLEX VIRUS 1se of a novel wild-type KOS-like herpesvirus constitu-
ively expressing the EGFP protein immediately after viral
ntry into cells.
he KOS/EGFP virus
We inserted the EGFP gene cassette within the inter-
enic region between the UL53 and UL54 genes imme-
iately after the poly-A sequence of the UL53 gene. The
urpose of this construction was to enable the monitor-
ng of viral entry through the detection of EGFP fluores-
ence. In addition, EGFP could serve as a fluorescent
arker for the isolation of recombinant viruses contain-
ng gK mutations by simultaneously transferring mutated
FIG. 6. Blocking of virus entry by HveAs:Fc soluble protein and by
nti-HveAs antibodies. (A and C–F) CHO/HveAs cells infected with
OS/EGFP virus at an m.o.i. of 10. (A) Untreated control. (B) CHO/sAevH
ontrol cells (transformed with the HveAs gene in the noncoding
rientation). (C and D) CHO/HveAs cells were pre-treated with pre-
mmune or anti-HveAs serum, respectively, for 30 min at room temper-
ture prior to infection. (E and F) KOS/EGFP virus was pre-treated for 30
in at room temperature with CHO/sAevH control supernates and
oluble HveAs:Fc, respectively, for 30 min at 4°C prior to infections.K genes and the EGFP gene cassette to viral genomes. qGFP was selected because this protein is capable of
mitting bright green fluorescence within cells in cell
ulture under physiological conditions without the re-
uirement of exogenous substances. In addition, EGFP
s highly stable under varying pH conditions, detergents
nd reducing agents enabling the direct measurement of
GFP accumulated expression (Chalfie et al., 1994;
halfie 1995). In this regard, EGFP detection provides a
seful alternative to b-galactosidase and other enzymes
ecause it does not require addition of toxic reagents
hat inactivate cells and viruses.
The growth characteristics and plaque morphology of
he resultant KOS/EGFP virus were similar to wild-type
OS virus, indicating that insertion of the EGFP gene
assette between the two essential genes, UL52 and
L54 as well as expression of the EGFP proteins did not
dversely affect virus replication. High levels of EGFP
xpression were achieved in KOS/EGFP virus-infected
ells that was easily detected by fluorescence micros-
opy and quantified by FACS analysis. KOS/EGFP fluo-
escence was detected through the use of a fluorescent
icroscope as early as 5–6 h p.i. and fluorescent
laques were readily visualized at 12 h p.i. Fluorescence
mitted from cells located within the center of each
laque increased with time, whereas newly recruited
ells appeared weakly fluorescent until EGFP accumu-
ated at later times. This radial feature of fluorescence
mission enables an improved, time-dependent visual-
zation of KOS/EGFP plaque formation in comparison
ith phase-contrast microscopy.
veAs mediates HSV entry
The functionality of the HveA receptor was demon-
trated principally by showing that CHO/HveA-trans-
ormed cells facilitated HSV-1 entry and that HSV-1 entry
nto these cells was blocked by either soluble HveA:Fc
rotein or anti-HveA antibodies (Montgomery et al.,
996). We performed similar experiments with the excep-
ion that viral entry into cells was monitored through
luorescence detection of the EGFP protein specified by
he KOS/EGFP virus. Collectively, these experiments
howed that HveAs mediates HSV virus entry in a spe-
ific manner. Undiluted amounts of anti-HveAs antibody
nd CHO cell supernatants containing soluble HveAs:Fc
rotein reduced viral entry into vero cells by ;40 and
0%, respectively, as measured by FACS (not shown).
he inability of anti-HveAs antibody and soluble
veAs:Fc to fully inhibit virus entry into Vero cells is due
o either the use of the blocking reagents at nonsaturat-
ng conditions or the presence of the HveC and other
eceptors on Vero cell surfaces (Geraghty et al., 1998).
he HveAs protein
Comparison of the cDNA-predicted amino acid se-
uences of HveA and HveAs proteins revealed conser-
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372 FOSTER, CHOULJENKO, AND KOUSOULASation of all cysteine residues with the exception of a
ingle cysteine missing in the membrane-spanning por-
ion of HveAs with respect to HveA. Furthermore overall
tructural features, which identified the HveA protein as
homolog to the TNF family of proteins, were conserved
Montgomery et al., 1996). However, there was a signif-
cant divergence at the amino acid level between the
veA and HveAs proteins. Most amino acid substitutions
ere concentrated within specific regions of the amino
erminus of the molecule and were to similar amino
cids that are not expected to drastically alter the sec-
ndary structure of the molecule. However, certain
mino acid substitutions were to dissimilar amino acids,
hich may alter structural properties of the protein.
hese were: S9 to P9, R12 to W12, P14 to S14, T22 to R22,
33 to P33, Q70 to L70, S79 to P79, T113 to R113, A115 to
115, A140 to R140, S172 to P172, G182 to Q182, and
183 to T183 in the extracellular portions of the proteins
nd S233 to P230, I256 to T253, T258 to I254, and E276
o I273 in the cytoplasmic portions of the proteins. Sig-
ificant insertions and deletions were noted in the pre-
icted intramembranous sequences of the HveAs and
veA proteins including a deletion that eliminated one
ysteine residue in the HveAs sequence in comparison
ith the HveA sequence. However, both intramembra-
ous sequences exhibited similar hydrophobic potential,
ndicating that both proteins should be effectively an-
hored into membranes. The carboxyl terminus of HveA
nded in amino acids P-N-H, which were not present in
he carboxyl terminus of the HveAs protein. Deletion of
he terminal 26 amino acids of the HveA protein did not
dversely affect the ability of this protein to mediate
erpes simplex virus entry (Montgomery et al., 1996);
herefore the carboxyl terminal differences between
veAs and HveA are not expected to significantly alter
he ability of HveAs to mediate HSV virus entry in com-
arison with HveA.
The primary sequences of gD specified by HSV and
imian herpes B virus (SHBV) are 58% identical. How-
ver, regions of gD that are important for HSV-1 virus
ntry into Vero cells are highly conserved in HSV-1,
SV-2, and SHBV (Bennett et al., 1992; Chiang et al.,
994). Furthermore anti-HSV-1 gD monoclonal antibodies
hat block HSV-1 binding to soluble HveA recognize
pitopes that overlap or are adjacent to these conserved
egions (Nicola et al., 1998). HSV enters into both HveA
nd HveAs-transformed cells efficiently, suggesting that
onserved domains in the extracellular portions of HveA
nd HveAs proteins may serve as common functional
ites for binding gD during viral entry.
MATERIALS AND METHODS
ells and viruses
African green monkey kidney (Vero) cells were ob-
ained from ATCC (Rockville, MD). Cells were propagated Dnd maintained in Dulbecco’s modified Eagle’s medium
DMEM; Sigma Chemical Co., St. Louis, MO) containing
odium bicarbonate and 15 mM HEPES, and supple-
ented with 7% heat inactivated fetal bovine serum
FBS). V27 cells carry a stably integrated copy of the
SV-1 (KOS) ICP27 gene and were kindly provided by Dr.
. M. Knipe, Harvard Medical School. These cells were
ultured in DMEM supplemented with 7% FBS (Rice and
nipe, 1990). HSV-1(KOS), the parental wild-type strain
sed in this study, was originally obtained from Dr. P. A.
chaffer (Dana-Faber Cancer Institute, Boston, MA).
SV-1(KOS) d27–1, which has a 1.6-kb BamHI-StuI dele-
ion of the ICP27 gene, also was kindly provided by Dr.
. M. Knipe and was propagated in V27 cells (Rice and
nipe, 1990).
eagents
Restriction and DNA modification enzymes were ob-
ained from New England BioLabs (Beverly, MA). RNase
nd Proteinase K were purchased from Boehringer
annheim (Indianapolis, IN). Gel fragment purification
atrix and buffers (Prep-a-gene) were obtained from
ioRad (Hercules, CA). Sequencing grade [35S] dATP was
btained from DuPont/NEN (Wilmington, DE). Amplitaq,
Tth XL Polymerase, and deoxynucleotide triphosphates
ere purchased from Perkin–Elmer (Foster City, CA). All
ynthetic oligonucleotide primers were synthesized by
he LSU Gene Probes and Expression Systems Labora-
ory ‘‘GeneLab’’ using phosphoamidite chemistry on an
pplied Biosystems ABI394 DNA/RNA synthesizer with
erkin–Elmer (Foster City, CA) reagents.
solation of the HveAs gene and construction of
lasmids
Total RNA was extracted from Vero cells using TRIRe-
gent (Molecular Research Center, Inc., Cincinnati, OH).
cDNA library was constructed using Ready-To-Go You-
rime First-Strand Beads (Pharmacia Biotech Inc., Upp-
ala, Sweden). All PCR amplifications were performed
sing the Gene-Amp PCR system 9600, AmpliTaq, and
ther Perkin–Elmer reagents (Perkin–Elmer, Norwalk,
T). PCR products were derived using HveA-specific
rimers (Montgomery et al., 1996) and were cloned into
lasmid pCR2.1 using the TA-cloning kit (Invitrogen Inc.,
arlsbad, CA) producing plasmid pCR/HveAs. The
loned HveAs gene was sequenced using dideoxy-chain
ermination methodology, and the predicted primary
tructure of the protein was obtained (GenBank Acces-
ion No. AF147720). The HveAs gene was isolated from
lasmid pCR/HveAs after restriction with EcoRI and
loned into plasmid pcDNA3.1Zeo1 in the coding and
oncoding orientations producing plasmids pCMV/
veAs and pCMV/sAevH, respectively. The extracellular
omain of HveAs (first 202 amino acids) was fused to a
NA fragment specifying the Fc portion of the mouse IgG
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373SIMIAN HveA-MEDIATED ENTRY OF HERPES SIMPLEX VIRUS 1eavy chain using PCR-assisted splice-overlap-exten-
ion (Chouljenko et al., 1996) and cloned into plasmid
CR3.1 using the eukaryotic TA-cloning kit (Invitrogen,
nc.), producing plasmid pCR/HveAs:Fc. Also, this portion
f the HveAs gene was cloned into plasmid pMALc2
NEB, Beverly, MA), producing plasmid pMAL/HveAs.
lasmid pTF9202 was constructed by inserting the gK
ene, after amplification with primer pair UL52KpnI2/
KSpeI (59-AACACCAACACTAGTGGTGGATGTCCT-
ATACC-39) into the unique KpnI and SpeI sites of
TF9201 (Foster et al., 1999). This plasmid was used to
ransfer the EGFP gene into the d27–1 viral genome.
onstruction of the HSV-1 (KOS)/EGFP recombinant
irus
Plasmid pTF9202 specifying the CMV-EGFP gene cas-
ette flanked by homologous HSV-1 sequences was
ransfected into 50% confluent Vero cells using Lipo-
ectamine (GIBCO-BRL, Gaithersburg, MD) according to
he manufacturer’s instructions. Twenty-four hours post
ransfection (h p.t.), the cells were infected at an m.o.i. of
0 with d27–1 virus (ICP27-null) as described previously
or the generation of the gK null virus, DgK (Jayachandra
t al., 1997). At 48 h p.i., the cells were freeze-thawed
hree times, and the resultant virus stocks were plated
nto Vero cells and overlaid with agarose. Virus plaques
ere visualized by fluorescent microscopy, individual
irus plaques were isolated, and virus was plaque puri-
ied five times on Vero cells.
iagnostic PCR
Primer pairs UL52KpnI2/gKTr2, and UL52KpnI2/CMV-
amHI were used to confirm the EGFP gene insertion as
escribed previously (Foster et al., 1999). Primer pair
L52KpnI2/d27–1a was used to detect the presence of
ontaminating d27–1 viral DNA. Reaction conditions for
L52KpnI2/gKTr2 and UL52KpnI2/d27–1a pairs were
8°C for 3 s and 72°C for 7 min, repeated for 30 cycles
sing rTth XL-Polymerase (Perkin–Elmer, Inc.). Reaction
onditions for the UL52KpnI2/CMVBamHI primer pair
ere 98°C for 3 s and 72°C for 3 min, repeated for 30
ycles using rTth XL-Polymerase.
onstruction of Chinese hamster ovary (CHO) cell
ines transformed with the HveAs or HveAs:Fc genes
Plasmid pCMV/HveAs, pCMV/sAevH, and pCR/HveAs:Fc
ere transfected into CHO cells using LipofectAmine
nd transformed cells were selected using Zeocin for the
irst two plasmids (Invitrogen, Carlsbad, CA) and G418
Sigma, Inc.) for the pCR/HveAs:Fc plasmid. Individual
HO colonies were isolated, expanded, and tested for
he presence of the HveAs gene using PCR and Southern
lotting. Croduction of anti-HveAs-specific antibodies
Plasmid pCMV/HveAs was used to generate mouse
nti-HveAs antibodies by direct injection into mice (ge-
etic immunization). Purified plasmid DNA was inocu-
ated intramuscularly into mice five times approximately
very 4 weeks. HveAs was expressed in E. coli as a
usion protein with the maltose binding protein (MBP) by
lasmid pMAL/HveAs and purified according to the man-
facturer’s instructions (NEB, Beverly, MA). Anti-HveAs
ntibodies were tested in immunoblots against the MBP/
veAs fusion protein essentially as described previously
Foster et al., 1999).
roduction of HveA:Fc by CHO-transformed cells
HveAs:Fc protein secreted in supernatant fluids of ;107
HO/HveAs:Fc-transformed cells was purified using pro-
ein A sepharose beads. Samples were resuspended in
DS–PAGE sample buffer and electrophoretically sepa-
ated in a 10% SDS–polyacrylamide gels. Following elec-
rophoretic separation, proteins were electrotransferred
o nitrocellulose membranes. Blots were blocked against
onspecific binding and incubated with horse radish
eroxidase conjugated goat anti-mouse secondary anti-
ody (Pierce, Rockford, IL) at a 1:50,000 dilution in TBS-T.
lots were visualized by autoradiography using the Pierce
uperSignal chemiluminescent detection kit (Pierce) as
er the manufacturer’s instructions.
hase-contrast and fluorescent microscopy
Subconfluent cell monolayers in 24-well plates were
nfected with the KOS/EGFP virus at an m.o.i. of 0.02 for
isualization of individual viral plaques by either phase
ontrast or fluorescence microscopy essentially as de-
cribed previously for the DgK/EGFP virus (Foster et al.,
999). Viral entry experiments were performed at m.o.i. of
0 and visualized by fluorescence microscopy at 24 h p.i.
ACS analysis
CHO-transformed cells expressing HveAs or Vero
ells were fixed with paraformaldehyde and incubated
ith anti-HveAs antibody for 1 h at 4°C. Next cells were
ashed three times with PBS buffer, incubated with
oat-anti-mouse FITC-conjugated secondary antibody
Sigma, Inc.), and analyzed by FACS. KOS- and KOS/
GFP-infected Vero cells were analyzed by FACS at 24 h
.i. as described previously (Foster et al., 1999).
nhibition of virus entry by anti-HveAs antibody and
oluble HveA-Fc protein
CHO/HveAs cells were incubated with either pre-im-
une or anti-HveAs serum for 1 h at room temperature
mmediately prior to infection with KOS/EGFP at a m.o.i.
f 10. One milliliter of supernatant fluids from either
HO/HveAs:Fc or CHO cells transformed with pCR3.1
(
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374 FOSTER, CHOULJENKO, AND KOUSOULAScontrol) was mixed with 1 ml of KOS/EGFP virus stock
1 3 108 PFU/ml) and incubated at 4°C for 1 h immedi-
tely prior to infection. The amount of virus used in these
xperiments was ;106 PFU per 105 CHO/HveAs cells.
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